Obtaining Undifferentiated Cells From Testis Biopsy
Primary Purpose
Azoospermia
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
analyse and proliferate the cells
Sponsored by
About this trial
This is an interventional treatment trial for Azoospermia
Eligibility Criteria
Inclusion Criteria:
-azoospermic patients
Sites / Locations
- IVI Valencia
Arms of the Study
Arm 1
Arm Type
No Intervention
Arm Label
tissue from biopsies
Arm Description
Outcomes
Primary Outcome Measures
Assessment of potential germinal and pluripotent of the isolated cultures.
•The spermatogonial cells isolated from testicular biopsies of azoospermic patients will be matured in vitro for thegeneration of sperm for infertility treatment.
* Undifferentiated cells of the testis biopsy will be characterized as degrees of plasticity for proof that they are capable of regeneration spermatogenesis.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01375062
Brief Title
Obtaining Undifferentiated Cells From Testis Biopsy
Official Title
Isolation, Culture and Characterization Stem Cells From Testis Biopsy
Study Type
Interventional
2. Study Status
Record Verification Date
March 2014
Overall Recruitment Status
Completed
Study Start Date
May 2009 (undefined)
Primary Completion Date
July 2011 (Actual)
Study Completion Date
July 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Igenomix
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to isolate and culture stem cell from adult human testicular biopsies for future transplantation in fertility preservation.
Detailed Description
Testicular biopsies were obtained from azoospermic patients as part of their diagnosis and work-up after obtaining a signed informed consent. A portion of each sample was mechanically dissected in PBS with 1% Pen/Strep. For enzymatic digestion samples were incubated with 0.5g/ml Collagenase type 1A for 20min and TripLE Select for 15min at 37ºC on a shaker and then filtered with 30µm and centrifuged at 1,000rpm. The pellets were seeded and incubated in embryonic stem cell media (hESC) with glial cell line-derived neurotrophic factor (GDNF 4ng/mL) for 5-7 days at 37ºC (1st culture). To identify and isolate SSCs they were marked with CD49f antibody and FACS sorted. Positive cells were cultured in gelatine plates containing hESC media with leukaemia inhibitory factor (LIF1000U/mL) (2nd culture).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Azoospermia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
65 (Actual)
8. Arms, Groups, and Interventions
Arm Title
tissue from biopsies
Arm Type
No Intervention
Intervention Type
Other
Intervention Name(s)
analyse and proliferate the cells
Intervention Description
Obtention of excess tissue from testicular biopsies and maintained in 4ºC until procedures.
Digestion of the biopsies through controlled enzymes
Replication of the cells
Selection undifferentiated cells
Expansion of the purification cells population
Characterization of the cell population
Assessment of pluripotent and germinal cell potential.
Possible maturation of the cells.
Primary Outcome Measure Information:
Title
Assessment of potential germinal and pluripotent of the isolated cultures.
Description
•The spermatogonial cells isolated from testicular biopsies of azoospermic patients will be matured in vitro for thegeneration of sperm for infertility treatment.
* Undifferentiated cells of the testis biopsy will be characterized as degrees of plasticity for proof that they are capable of regeneration spermatogenesis.
Time Frame
one month
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
-azoospermic patients
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carlos Simon, MDPhD
Organizational Affiliation
IVI Valencia
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Marcia Riboldi, PhD
Organizational Affiliation
Fundación IVI
Official's Role
Principal Investigator
Facility Information:
Facility Name
IVI Valencia
City
Valencia
ZIP/Postal Code
46015
Country
Spain
12. IPD Sharing Statement
Learn more about this trial
Obtaining Undifferentiated Cells From Testis Biopsy
We'll reach out to this number within 24 hrs